About Subhag
Subhag is a company based in Bengaluru (India) founded in 2018 by Vikram Rajput. Subhag has raised $693.93 thousand across 7 funding rounds from investors including Venkatesh Ramaswamy, Epari Vikash and Nathiram Goyal. Subhag offers products and services including V-Conceive and AndroWash. Subhag operates in a competitive market with competitors including Béa Fertility, Mosie Baby, BendFlex, FertiliTech and Biorocks, among others.
- Annual Revenue₹51.4 Lakh
FY 2024 · +112% YoY
- Net Loss-₹23.4 Lakh
FY 2024 · -45% margin
- EBITDA-₹17.5 Lakh
FY 2024 · -34% margin
- Total Equity Funding$693.93K (USD)
in 7 rounds
- Latest Funding Round$180.95K (USD), Angel Round
Feb 2024
Associated legal entities of Subhag
Subhag operates through Subhag Healthtech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Subhag Healthtech Private Limited CIN U74999MH2018PTC304037 | Active | 11 Jan 2018 | Mumbai, Maharashtra | ₹0.5 Cr | – | 4 | View details |
Products & Services of Subhag
Subhag offers a comprehensive portfolio of products and services, including V-Conceive and AndroWash.
A cup for DIY intrauterine insemination to aid conception at home.
Automated tool to enhance sperm quality for fertility treatments.
Funding Insights of Subhag
Subhag has successfully raised a total of $693.93K across 7 strategic funding rounds. The most recent funding activity was a Angel Round of $180.95 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $693,929
- Total Rounds 7
- Last Round Angel Round — $180,951
- First Round $185,488
(Mar 2019)
- Investors Count 19
All 7 funding rounds of Subhag with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $180,951 | Angel Round | $7.25M | – | |
| Mar 2023 | $36,704 | Debt – Conventional | – | – | |
| Mar 2023 | $24,469 | Angel Round | – | Namita Thapar | – |
| Nov 2022 | $64,935 | Angel Round | $2.44M | – | – |
| Mar 2022 | $65,443 | Angel Round | $••••• | Venkatesh Ramaswamy | |
| Mar 2020 | $172,643 | Angel Round | $••••• | Devendra Kumar Chandrakar | |
| Mar 2019 | $185,488 | Angel Round | $••••• | Devendra Kumar Chandrakar |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2024 | $7.25M | •••••••• |
| Nov 2022 | $2.44M | •••••••• |
| Mar 2022 | $••••• | •••••••• |
| Mar 2020 | $••••• | •••••••• |
| Mar 2019 | $••••• | •••••••• |
Full valuation and stage history of Subhag
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $7.25M (Feb 2024). 19 investors in total: 0 institutional and 19 angel.
Investors in Subhag
Subhag has secured backing from 19 investors, including angel investors. Prominent investors backing the company include Venkatesh Ramaswamy, Epari Vikash and Nathiram Goyal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VR Venkatesh Ramaswamy | - | – | unknown_6e4146dcc64a423f9 | - |
EV Epari Vikash | - | – | unknown_49846775ed984e7e9 | - |
NG Nathiram Goyal | - | – | unknown_64e7b068cb2c4015b | - |
SM Swati Mishra | Angel investor and entrepreneur, focusing on early-stage Indian startups. | – | unknown_416619f4a66b4e0e8 | - |
PP Paras Pant | - | – | unknown_01cf91ba170c40f7a | - |
VK Vivek Kumar | Angel investor, ex-entrepreneur, focused on early-stage Indian startups | – | unknown_abd6782a24a34e83a | - |
AR Amit Rathod | Angel investor and entrepreneur, founder of Quicko, focusing on fintech and tech startups | – | unknown_593d9cffcb6a41a6b | - |
DT Dipendra Tulsiyan | - | – | unknown_e4f2eb2bc3bc419ba | - |
PJ Pushkar Joshi | - | – | unknown_9fecb4e217a14711b | - |
SK Sridhar Kotha | - | – | unknown_9ee6379e088148de9 | - |
Investor details for Subhag
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Subhag Healthtech Private Limited (Subhag)
Subhag Healthtech Private Limited is the primary company behind Subhag. The board of Subhag Healthtech Private Limited currently have 2 directors; the longest-serving is Vikram Singh Rajpoot, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikram Singh Rajpoot DIN 06791552 | Director | 11 Jan 2018 | 8 yrs 8 mo | Subhag Healthtech Private Limited |
| Sohan Kumar Sahu DIN 08828026 | Director | 01 Mar 2021 | 5 yrs 7 mo | Subhag Healthtech Private Limited |
People of Subhag
1 people are tracked at Subhag (1 in leadership).
| Name | Role | Group |
|---|---|---|
Vikram Rajput | Founder & CEO | Leadership |
Complete people profiles for Subhag
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Subhag
Figures of Subhag Healthtech Private Limited, the primary company behind Subhag, for FY 2024. Revenue was ₹51.4 Lakh (+112% year on year). Net loss was -₹23.4 Lakh (-45% margin). EBITDA was -₹17.5 Lakh (-34% margin). Revenue has grown at a compounded annual rate of +11% over three years and +115% over five years.
- ₹51.4 LakhRevenue · FY 2024 · +112% YoY
- -₹23.4 LakhNet loss · -45% margin
- -₹17.5 LakhEBITDA · -34% margin
- ₹1.2 LakhPaid-up capital
- +11%Revenue CAGR, 3 years
- +115%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Subhag Healthtech Private Limited are on its company page.
Detailed financial statements for Subhag
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Subhag
4 dated milestones of Subhag across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Subhag is founded.
- Funding First funding round of $185K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $181K.
Competitors of Subhag
Subhag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Béa Fertility, Mosie Baby, BendFlex, FertiliTech and Biorocks, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beafertility.com | 2020 | London, United Kingdom | $4.31M | 12 | Provider of a device for fertility treatment | |
| mosiebaby.com | 2014 | Austin, United States | $1.08M | 5 | Home insemination solutions are offered for women's conception needs. | |
| bendflex.in | 2015 | Bengaluru, India | – | – | A medical device is developed to enhance IVF success rates. | |
| fertilitech.com | 2003 | Aarhus, Denmark | $44M | 110 | Embryo selection in IVF clinics is enhanced by time-lapse technology. | |
| biorocks.net | 2022 | Sha Tin, China | – | – | Provider of medical device for embryo and oocyte preservation | |
| anecova.com | 2004 | Lausanne, Switzerland | $5.06M | – | Delivers comprehensive solutions in assisted reproductive technologies for medical professionals. | |
| zhongyuanyihe.com | 2014 | Shenyang, China | – | – | Creates innovative medical devices for in vitro fertilization. |
Detailed competitors of Subhag
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Subhag
The website of Subhag (subhag.in) receives about 2K visits a month.
- Monthly visits2K
▲ 25.1% vs previous month
Latest news on Subhag
Complete news archive for Subhag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Subhag
10 companies that operate in the same segment as Subhag (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Subhag
Subhag was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Subhag is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Vikram Rajput is the current CEO of Subhag. They have also founded this company.
Subhag is a funded company, having raised a total of $693.93K across 7 funding rounds to date. The company's 1st funding round was a Angel Round of $185.49K, raised on Mar 2019.
The primary company behind Subhag, Subhag Healthtech Private Limited, reported revenue of ₹51.4 Lakh for FY 2024, up 112% year on year.
Subhag was founded in 2018 in Bengaluru, India, as a developer of medical devices focused on infertility treatments. Patented technology is utilized to create Intra Uterine Insemination kits, including products such as Androwash and V-conceive. Operations center on producing these specialized tools for reproductive health applications within the healthcare sector.
Subhag's top competitors include Béa Fertility, FertiliTech and BendFlex.
Subhag offers V-Conceive and AndroWash.
Subhag has 19 investors. Key investors include Venkatesh Ramaswamy, Epari Vikash, Nathiram Goyal, Swati Mishra, and Paras Pant.
The valuation of Subhag is $7.25M as of Feb 2024.
Subhag operates through Subhag Healthtech Private Limited.
The legal entities of Subhag currently have 3 directors, including Sohan Kumar Sahu, Vikram Singh Rajpoot, Vikram Singh Rajput.